At the same time, BCP-ALL showed a lower ratio of s/u XBP1 expression compared to T-ALL (Figure 4B), but only in BCP-ALL did the s/u XBP1 expression ratio correlate negatively with cytotoxicity to bortezomib (Figure 4C,D). This evidence concerns the gene XBP1 and acute lymphoblastic leukemia.